QSAM Common Stock (QB)

This Schedule 13G is being filed by Strategic Planning Assets, Ltd. (“Strategic Planning”) and Simon Nai-Cheng Hsu (“Simon Hsu” or “Mr. Hsu”) with regard to common stock and Series B stock convertible into common stock of QSAM Biosciences, Inc., a Delaware corporation. Strategic Planning is an investment holding company. Mr. Hsu, its sole director and 100% shareholder, takes all major decisions on behalf of Strategic Planning, including investment decisions. As such, the power to vote and dispose or direct the disposition of securities on behalf of Strategic Planning is vested in Mr. Hsu. As of the date of this report, Mr. Hsu has the sole power to vote and dispose or direct the disposition of 3,430,632 shares of common stock (including securities convertible into common stock) of the Issuer owned by Strategic Planning. This consists of 1,868,132 shares of common stock and Series B preferred stock convertible into 1,562,500 shares of common stock.

Item 3. If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a: Not applicable

Item 4. Ownership

*Consisting of 1,868,132 shares of common stock and 1,562,500 shares of common stock receivable upon conversion of Series B preferred stock

**The percentage is calculated based upon total outstanding shares of 66,169,164 as of December 17, 2021, as provided by QSAM Biosciences, Inc.

Item 5. Ownership of Five Percent or Less of a Class

Not applicable.

Item 6. Ownership of More than Five Percent on Behalf of Another Person

Not applicable.

Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company or Control Person

Not applicable.

Item 8. Identification and Classification of Members of the Group

Not applicable.

Item 9. Notice of Dissolution of Group

Not applicable.

Item 10. Certifications

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Dated: January 5, 2022

Joint Filing Agreement Pursuant to Rule 13d-1

This agreement is made pursuant to Rule 13d-1(k)(1) under the Securities and Exchange Act of 1934 (the “Act”) by and among the parties listed below, each referred to herein as a “Joint Filer”. The Joint Filers agree that a statement of beneficial ownership as required by Sections 13(g) or 13(d) of the Act and the Rules thereunder may be filed on each of their behalf on Schedule 13G or Schedule 13D, as appropriate, and that said joint filing may thereafter be amended by further joint filings. The Joint Filers state that they each satisfy the requirements for making a joint filing under Rule 13d-1.

Dated: January 5, 2022